Back

Inflammation and Fibrosis Markers Predict Adverse Outcomes in Arrhythmogenic Cardiomyopathy: An Integrated Multiomics Study

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Basic science and arrhythmia pathophysiology Pathophysiology and Mechanisms EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Deniz Akdis

University Heart Center, Zurich (Switzerland)

5 More presentations in this session

Presentation thumbnail
Regional specific changes in cardiac resident macrophages and fibroblasts modulate long-term atrial fibrillation maintenance
Ms A. Simon Chica (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Sex-specific differences in left atrial fibrotic, structural and electrical remodeling in atrial fibrillation: P-wave duration enables sex-specific outcome prediction after pulmonary vein isolation
Doctor T. Huang (Lucerne, CH)
Abstract Slides Video
Presentation thumbnail
Differentiating mechanisms of long duration ventricular fibrillation in acute ischemic myocardium vs. chronic infarct in an in-vivo porcine model
Doctor J. Tonko (London, GB)
Abstract Slides Video
Presentation thumbnail
Interplay between ventricular electrical and mechanical activity as a trigger for torsades de pointes in drug-induced long-QT 2 syndrome
Doctor P. Deissler (DE)
Abstract Slides Video
Presentation thumbnail
Stiffness-driven electrical remodeling: exploring mechanosensitive dynamics in hiPSC-CM
Doctor N. Ullrich (Bern, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Basic science and arrhythmia pathophysiology
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Session
What you always wanted to know about OMICs: translating cutting-edge technology into clinical application
thumbnail
Congress Session
Cardiomyopathies uncovered
thumbnail
Congress Session
Late-Breaking Basic & Translational Science

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources